Physician profile
Laurel Yee
NPI 1417577131
$2,831.56
in general payments reported to CMS, 2019-2025
10 companies · $571 in 2025
The $571 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,637 · 2024: $624 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,044 · Travel and Lodging: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,044.34 |
| Travel and Lodging | $787.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,828.11 | 2023-2025 | Prostep, Augment Injectable, Prostep Mica |
| Integra Lifesciences Corporation | $318.99 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $193.31 | 2024 | |
| Depuy Synthes Sales INC. | $128.14 | 2024 | Motoband, Minibunion, Hammerlock |
| Linvatec Corporation | $122.66 | 2023 | Colink Plating System, Biobrace 23mm |
| Kci USA, INC. | $106.72 | 2023 | V.A.C. Dermatac |
| Suvon Surgical LLC | $56.30 | 2024 | |
| Paratek Pharmaceuticals, INC. | $33.75 | 2024 | Nuzyra |
| Axogen | $22.85 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Melinta Therapeutics, LLC | $20.73 | 2024 | Orbactiv, Kimyrsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.